Soleno Therapeutics (SLNO) Short-term Investments (2024 - 2026)

Soleno Therapeutics (SLNO) has 3 years of Short-term Investments data on file, last reported at $122.6 million in Q1 2026.

• On a quarterly basis, Short-term Investments fell 41.24% year-over-year to $122.6 million in Q1 2026; TTM through Mar 2026 was $122.6 million, a 41.24% decrease from a year earlier, with the FY2025 full-year figure at $235.4 million, up 15.65% from the prior year.
• Short-term Investments for Q1 2026 stood at $122.6 million, down from $235.4 million in the prior quarter.
• Over the last five years, Short-term Investments for SLNO reached as high as $252.3 million in Q3 2025 and fell as low as $106.8 million in Q1 2024.
• Historically, Short-term Investments has averaged $195.2 million across 3 years, with a median of $208.6 million in 2025.
• Across the five-year window, Short-term Investments surged 95.32% in 2025 and plunged 41.24% in 2026, its largest moves.
• Year by year, Short-term Investments stood at $203.5 million in 2024, then gained by 15.65% to $235.4 million in 2025, then slumped by 47.92% to $122.6 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $122.6 million in Q1 2026, $235.4 million in Q4 2025, and $252.3 million in Q3 2025.